Acute myocardial infarction: selective or ISA-type beta-adrenoceptor blocking drug?

Pharmacological properties of beta-adrenoceptor blocking drugs

Rapid Diagnosis of Acute Myocardial Infarction

To improve the specificity of biochemical markers of myocardial infarction (MI) a method to measure cardiac troponin-I (CTn-I) was developed. CTn-I is a protein unique to cardiac muscle and is released after MI. Consecutive 150 patients admitted to the coronary care unit was studied. Value of CTn-I was determined in all samples. CTn-I concentration in the MI patients group was increased com...

Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months.

OBJECTIVE To investigate whether myocardial beta-adrenoceptor (beta-AR) downregulation precedes and predicts left ventricular (LV) dilation after acute myocardial infarction (AMI), we measured beta-AR density within four weeks of AMI and correlated it with serial measurements of LV volumes. BACKGROUND Patients who develop heart failure following AMI have an increased sympathetic drive to the ...

Emotional Triggers of Acute Myocardial Infarction

Introduction: Cardiovascular diseases are the leading causes of death around the world. Identification of triggers that lead to acute coronary events in ischemic heart diseases and their prevention can reduce the complications of myocardial infarction. Objective: The purpose of this study is to determine emotional triggers in patients with acute Myocardial Infarction (MI). Materials and Metho...

Drug-eluting stents for acute myocardial infarction.

Routine stent-implantation in primary coronary intervention (PCI) for acute myocardial infarction (AMI) has been shown to have a better clinical outcome than balloon angioplasty mainly because of reduction in restenosis rate and reocclusion. Drug eluting stents (DES) have recently been proven to further reduce restenosis and revascularization rate in comparison to bare metal stent (BMS) in elec...